1. Home
  2. CDZI vs MNPR Comparison

CDZI vs MNPR Comparison

Compare CDZI & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$6.68

Market Cap

444.6M

Sector

Utilities

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$70.31

Market Cap

421.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZI
MNPR
Founded
1983
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
444.6M
421.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CDZI
MNPR
Price
$6.68
$70.31
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$101.42
AVG Volume (30 Days)
857.9K
343.0K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,979,000.00
N/A
Revenue This Year
$58.18
N/A
Revenue Next Year
$32.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
188.33
N/A
52 Week Low
$2.13
$26.06
52 Week High
$6.96
$105.00

Technical Indicators

Market Signals
Indicator
CDZI
MNPR
Relative Strength Index (RSI) 61.49 54.51
Support Level $6.21 $67.33
Resistance Level $6.96 $72.75
Average True Range (ATR) 0.43 5.71
MACD 0.06 1.29
Stochastic Oscillator 78.12 92.77

Price Performance

Historical Comparison
CDZI
MNPR

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: